Nallakkandi Rajeevan

7PUBLICATIONS
39CO-AUTHORS
Powder and particle technologyTime-series analysisPredictive and prognostic markersPacific Peoples psychologyInformation systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction.

Anand Reghuvaran, Ashwani Kumar, Qisheng Lin

|Feb 04, 2025
Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.

George N Ioannou, Kristin Berry, Nallakkandi Rajeevan

|Oct 30, 2023
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation.

George N Ioannou, Kristin Berry, Nallakkandi Rajeevan

|Aug 12, 2021
Polygenic Breast Cancer Risk for Women Veterans in the Million Veteran Program.

Jessica Minnier, Nallakkandi Rajeevan, Lina Gao

|Jul 31, 2019
Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veterans.

Joel Gelernter, Ning Sun, Renato Polimanti

Pageof 2